Specific blockade of TF functions in tumor cells by TF knockdown, monoclonal antibody (mAb) or by tissue factor pathway inhibitor (TFPI) resulted in inhibition of tumor growth, metastasis and angiogenesis [11, 25–32]. This evidence concerns the gene TFPI and neoplasm.